Top news of the week: 15.03.2022.
Healthcare
Western Drugmakers Are Still Providing Medicines to Russia
Healthcare companies say they are duty-bound to continue supplying drugs, vaccines and medical equipment to Russia, though Western sanctions and other measures have thrown up hurdles.
Unique UK ecosystem can spur cell and gene therapies investment
The UK government and regulators have an opportunity to build a unique ecosystem in which businesses developing innovative new treatments based on human cells or genes can thrive.
Orcas doctor to climb to Mount Everest Base Camp in campaign to raise $1m for cancer research
An Orcas Island man is tackling the unknown head-on.
Welcome to Dave Hoffman's Climb to Fight Cancer Webpage!
Amanda Martin & Mark Cairns When I joined the Climb to Fight Cancer as a part of Luke Timmerman's team of biotech industry professionals planning to trek to Everest Base Camp in …
Biotech Firm Should Increase Sales by 20% This Year Research Report
This immunotherapy company's outlook for 2022 is positive, noted an H.C. Wainwright & Co. report.
AYOXXA receives fresh capital for commercial growth in Europe, US and Asia led by Prosnav Capital
AYOXXA Biosystems GmbH, active in the development of multiplex protein analysis assays for drug discovery and translational research, today announced the successful closing of a financing ...
This Is How Big Pharma Wins
Two years into the pandemic, the industry has evaded reforms a supermajority of voters want.
Return of the mammoth? George Church-backed company launches with $15 million for elephant-sized quest
The funding is likely to force policymakers to engage more directly with what has until now seemed more science fiction than reality.